|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2006; 48:833-838, doi:10.1016/j.jacc.2006.05.045
(Published online 14 June 2006). © 2006 by the American College of Cardiology Foundation |
* Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
Departments of Cardiovascular Medicine and Diagnostic Radiology, Cleveland Clinic Foundation, Cleveland, Ohio.
Manuscript received March 3, 2006; revised manuscript received April 18, 2006, accepted May 15, 2006.
* Reprint requests and correspondence: Dr. Steven E. Nissen, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195. (Email: nissens{at}ccf.org).
OBJECTIVES: The purpose of this study was to evaluate the effects of normal blood pressure (BP), pre-hypertension, and hypertension on progression of coronary atherosclerosis.
BACKGROUND: The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) classifies BP as normal, pre-hypertension, and hypertension. The effects of these categories on progression of coronary atherosclerosis are unknown.
METHODS: The 274 patients who completed the intravascular ultrasound (IVUS) substudy of the CAMELOT (Comparison of Amlodipine Versus Enalapril to Limit Occurrences of Thrombosis) trial were included. The entry criteria were 
1 angiographic coronary stenosis >20% and diastolic BP <100 mm Hg. Patients underwent a baseline coronary IVUS, which was repeated after 2 years of amlodipine, enalapril, or placebo therapy. The BP was evaluated periodically, and the averages of the measurements were used in the analyses.
RESULTS: Mean BP throughout the study was 127.0 ± 12.0/75.5 ± 6.8 mm Hg. In multivariable analysis, significant determinants of progression included systolic BP (r = 0.16; p = 0.006) and pulse pressure (r = 0.14; p = 0.02). Patients with "hypertensive" average BP had a 12.0 ± 3.6 mm3 (least-square mean ± SE) increase in atheroma volume, those with "pre-hypertensive" BP had no major change (0.9 ± 1.8 mm3), and those with "normal" BP had a decrease of 4.6 ± 2.6 mm3 (p < 0.001 by analysis of covariance; p < 0.05 for comparison of all pairs).
CONCLUSIONS: The most favorable rate of progression of coronary atherosclerosis is observed in patients whose BP falls within the "normal" JNC-7 category (i.e., systolic BP <120 mm Hg and diastolic BP <80 mm Hg). This study suggests that in patients with coronary artery disease, the optimal BP goal may be substantially lower than the <140/90 mm Hg level.
| |||||||||||
This article has been cited by other articles:
|
|
 |
|
  I Sipahi, E M Tuzcu, K-W Moon, S J Nicholls, P Schoenhagen, J Zhitnik, T D Crowe, S Kapadia, and S E Nissen Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study Heart, May 1, 2008; 94(5): 623 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Ho, D. J. Magid, S. M. Shetterly, K. L. Olson, P. N. Peterson, F. A. Masoudi, and J. S. Rumsfeld Importance of Therapy Intensification and Medication Nonadherence for Blood Pressure Control in Patients With Coronary Disease Arch Intern Med, February 11, 2008; 168(3): 271 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Hypertension, August 1, 2007; 50(2): e28 - e55. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Circulation, May 29, 2007; 115(21): 2761 - 2788. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Nissen, J.-C. Tardif, S. J. Nicholls, J. H. Revkin, C. L. Shear, W. T. Duggan, W. Ruzyllo, W. B. Bachinsky, G. P. Lasala, E. M. Tuzcu, et al. Effect of Torcetrapib on the Progression of Coronary Atherosclerosis N. Engl. J. Med., March 29, 2007; 356(13): 1304 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Messerli, G. Mancia, C. R. Conti, and C. J. Pepine Blood Pressure Levels on Progression of Coronary Atherosclerosis J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1369 - 1369. [Full Text] [PDF]
|
|
|
|
|
|
I. Sipahi, E. M. Tuzcu, and S. E. Nissen Reply J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1369 - 1370. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Keidar, A. Strizevsky, A. Raz, and A. Gamliel-Lazarovich ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects Nephrol. Dial. Transplant., February 1, 2007; 22(2): 597 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daly, G. DeBacker, and K. Fox Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology: reply Eur. Heart J., December 1, 2006; 27(23): 2903 - 2903. [Full Text] [PDF]
|
|
|
|
|
|
J. Tobis and G. C. Fonarow Optimal Blood Pressure Levels in Patients With Coronary Artery Disease J. Am. Coll. Cardiol., August 15, 2006; 48(4): 839 - 840. [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
